Schizophrenia

Longitudinal, multi-source, curated datasets, offering rapid access to deep clinical data, insights and outcomes in Schizophrenia (SCZ).

Research-Grade RWD in Schizophrenia

Unmet Need

Top 15

Schizophrenia is one of the top 15 leading causes of disability worldwide (NIH), and an estimated economic burden of $343.2 billion in the US in 2019 (NIH).

Deep Clinical Data

8,400*+

Schizophrenia patients with deep clinical data

*Counts complete through Q2 2024

A Closer Look at the Schizophrenia Network

730,000 total Schizophrenia patients in the OM1 Real-World Data Cloud

 

 

Publications

Doane M, Bessonova L, Friedler H, Mortimer K, Cheng H, Brecht T, O’Sullivan A, Cummings H, McDonnell D, Meyer J. Weight Gain and Comorbidities Associated With Oral Second-Generation Antipsychotics: Analysis of Real-World Data for Patients With Bipolar I Disorder or Schizophrenia. BMC Psychiatry. 2022; 22(114).

Posters

Doane M, Bessonova L, Mortimer K, Cheng H, Donadio G, Brecht T, O’Sullivan A, Cummings H, McDonnell D, Meyer J. Weight Gain and Treatment Interruptions With Second-Generation Oral Antipsychotics: Analysis of Real-World Data Among Patients With Schizophrenia or Bipolar I Disorder. Psych NEI November 2020.

Award-Winning Research Team

Our team of award-winning researchers have authored hundreds of publications, including scientific posters, articles in peer-reviewed journals, white papers, and books.

Request a Meeting

  • This field is for validation purposes and should be left unchanged.